Since IDO+ MDSCs have been reported as essential for Treg induction and preventing the initiation of autoimmune disorders [26,35,60], decreased IDO levels in MDSCs from CME patients could explain, at least in part, regulatory T and B cell down-regulation in the same patient cohort. The gene discussed is IDO1; the disease is autoimmune disease.